Work

BMI percentile trajectories and liver enzyme changes in children with metabolic dysfunction–associated steatotic liver disease: A longitudinal cohort study

Year: 2026
Type: article
Study design: Observational Study
Abstract: OBJECTIVES: The incidence of pediatric obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are rapidly rising. However, the impact of dynamic body mass index (BMI) changes on liver chemistries remains understudied. We investigated the association between longitudinal changes in BMI percentile and changes in liver chemistries among children with MASLD. METHODS: In this multicenter study, 1169 children with biopsy-confirmed MASLD enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network were followed for a mean of 4.0 years. BMI percentiles were calculated using the lambda-mu-sigma method with an extended metric to capture nuances at extreme values. Generalized linear mixed-effects models with random effects for patients and clinics were applied, and inverse probability treatment weighting adjusted for demographics and baseline histologic features. Sensitivity analyses stratified by sex and ethnicity assessed robustness. RESULTS: Participants (mean age 13 years; 72% Hispanic) with higher BMI percentiles exhibited elevated blood pressures, increased insulin levels, and a lower frequency of the patatin-like phospholipase domain-containing protein 3 (PNPLA3) GG variant. Each 5-unit increase in BMI percentile was independently associated with a 23% increase in alanine aminotransferase (1.23; 95% confidence interval [CI], 1.17-1.30), a 13% increase in aspartate aminotransferase (1.13; 95% CI, 1.09-1.17), and a 12% increase in γ‑glutamyl transferase (1.12; 95% CI, 1.08-1.16). CONCLUSIONS: Longitudinal increases in BMI percentile are independently associated with worse liver chemistry in pediatric MASLD. Routine monitoring of BMI trajectories, alongside early weight management strategies, may be critical to mitigating disease progression. Trial Registration ClinicalTrials.gov: NCT01061684, NCT04454463.
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,780
OpenAlex ID: W7236716491
FWCI:
Cites: 23
Cited by:
Related to: 10